0001104659-23-130581.txt : 20231229 0001104659-23-130581.hdr.sgml : 20231229 20231229191355 ACCESSION NUMBER: 0001104659-23-130581 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myles Edward H CENTRAL INDEX KEY: 0001358219 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38501 FILM NUMBER: 231529114 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Scholar Rock Holding Corp CENTRAL INDEX KEY: 0001727196 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823750435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-259-3860 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 tm2333989-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-12-29 0 0001727196 Scholar Rock Holding Corp SRRK 0001358219 Myles Edward H 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 COO & CFO 1 Common Stock 2023-12-29 4 M 0 12459 4.86 A 181243 D Common Stock 2023-12-29 4 S 0 12159 18.8157 D 169084 D Common Stock 2023-12-29 4 S 0 300 19.5100 D 168784 D Stock Option (Right to Buy) 4.86 2023-12-29 4 M 0 24914 0 D 2032-06-16 Common Stock 24914 49836 D These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2023. Consists of 12,459 shares of common stock and 168,784 restricted stock units ("RSU"). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.24 to $19.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.25 to $19.64, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 168,784 RSUs and 300 shares of common stock. Consists solely of RSUs. Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. /s/ Junlin Ho, Attorney-in-Fact for Edward H. Myles 2023-12-29